Panic disorder (PD) and post-traumatic stress disorder (PTSD) impact individual health and wellbeing, productivity at work, and overall healthcare costs. As part of a quality improvement initiative, Highmark, Inc., investigated how treating panic disorder patients with a digital therapeutic impacted patient outcomes and medical costs.

WATCH THE AMERICA’S HEALTH INSURANCE PLANS (AHIP) WEBINAR TO LEARN:

• Why Highmark pursued new options for treating PD and PTSD
• How an easy to use, at-home digital therapeutic treats a key underlying physiological factor for PD and PTSD that traditional treatments don’t address
• The study results: significant clinical outcome improvements and cost reductions

05426 Rev A